Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-084310
Filing Date
2025-04-17
Accepted
2025-04-17 16:05:27
Documents
27
Period of Report
2025-05-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d901557ddef14a.htm   iXBRL DEF 14A 923052
6 GRAPHIC g901557g00g01.jpg GRAPHIC 5381
7 GRAPHIC g901557g00g02.jpg GRAPHIC 51514
8 GRAPHIC g901557g00g03.jpg GRAPHIC 3079
9 GRAPHIC g901557g00g04.jpg GRAPHIC 2744
10 GRAPHIC g901557g00g05.jpg GRAPHIC 2806
11 GRAPHIC g901557g01g02.jpg GRAPHIC 56899
12 GRAPHIC g901557g02g01.jpg GRAPHIC 1507
13 GRAPHIC g901557g02g02.jpg GRAPHIC 1828
14 GRAPHIC g901557g02g03.jpg GRAPHIC 1398
15 GRAPHIC g901557g56a01.jpg GRAPHIC 120151
16 GRAPHIC g901557g57a01.jpg GRAPHIC 116629
  Complete submission text file 0001193125-25-084310.txt   2674266

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fate-20241231.xsd EX-101.SCH 3358
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fate-20241231_def.xml EX-101.DEF 2278
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fate-20241231_lab.xml EX-101.LAB 2491
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fate-20241231_pre.xml EX-101.PRE 1315
29 EXTRACTED XBRL INSTANCE DOCUMENT d901557ddef14a_htm.xml XML 268799
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

EIN.: 651311552 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36076 | Film No.: 25847282
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)